Dr Meghan Thomas explains why new research for medicinal cannabis is so important, what her role is with the medicinal cannabis industry and future research studies in development.
Australia’s Queensland University of Technology (QUT) is set to research the effectiveness, dosages and side-effects related to THC and CBD in kids with cancer, after being given almost $700,000.
The Lambert Initiative for Cannabinoid Therapeutics and the Sydney Pharmacy School at the University of Sydney are surveying pharmacists to see if they are ready for medical cannabis prescriptions.
Bod Australia is set to release a new cannabigerol (CBG) product, which will be sold under the MediCabilis brand. This will be distributed to various medical facilities within the UK.
The latest budget from the Australian Federal Government contains $1.5 million for a trial looking in to personalised medicinal cannabis dosing in cancer patients.
after obtaining $1.5 million in from federal government funding, a young researcher will lead the trial of 176 South Australian advanced cancer patients, and how medicinal cannabis can help.
Neurotech International Limited (ASX:NTI) is opening a clinical study trial in 20 children aged between 5-17 years, who have Autism Spectrum Disorder (ASD).
For the first time, a medicinal cannabis drug has been listed on the Australian Pharmaceutical Benefits Scheme (PBS). This means that those who suffer from dravet syndrome, a rare form of epilepsy, can get treatment.
A warning has been issued from the Therapeutics Goods Administration (TGA) in Australia, over potential fake, and illegal selling of cannabis medications. Aussies should watch for counterfeit products that may be harmful.
Over the past few years, more and more Australians, and indeed many people worldwide, have had an increased interest in using cannabis for a medical purpose.
CBD is short for cannabidiol, which is an element of the cannabis plant. CBD is good for use in medical settings as it can help with a variety of ailments, without getting you high.
Byron Bay-based company ANTG has already sent shipments of medicinal cannabis to Europe, but soon the Australian Natural Therapeutics Group would like to export to the New Zealand market.
The first ever medicinal cannabis medication is soon to be on the Pharmaceutical Benefits Scheme, which will help with children suffering from a rare form of epilepsy (Dravet syndrome).
How much evidence do we really have on the benefits of using cannabis to treat chronic pain and other physical ailments? NDARC director Michael Farrell discusses this with host Norman Swan on ABC Radio’s National Health Report.
MG Health, based in Lesotho is the first cannabis company in Africa to receive a licence to export cannabis flowers, oil, and other extracts, to the EU for medicinal cannabis medication. Germany will be the first country to receive an import.
Views around cannabis, particularly in treating various ailments and disorders are rapidly changing. This article looks at what exactly medical cannabis is, what treatments are available within Australia and how they are taken.
Although the use of cannabis for medical reasons has been around for several years in Australia, how hard is it to get your hands on medicinal cannabis? This article looks at the laws within each Australian state.
If you always thought cannabis users were rather lazy, ‘stoner’ types, you may be proved wrong in this new study, showing a potential relationship between cannabis use and increased exercise.
Listen to this audio clip of pain experts discussing whether medical cannabis is really that effective. A study published in the Australian Medical Journal found it is no more effective than a placebo for those who have who acute lower back pain.
ECS Botanics has just dispatched its first commercial shipment of medicinal cannabis from their large medicinal cannabis facility in north-western Victoria. The shipment will supply both locals and overseas consumers.
The Australian Natural Therapeutics Group (ANTG) already has their medicinal cannabis crop growing close to Byron Bay, near Armidale. Now they are looking to move its headquarters to the popular beach town.
The generally conservative area of Toowoomba will now be the proposed place for two medical cannabis companies to build a huge cannabis farm. The farm will hope to produce 500 tonnes of medicinal cannabis each year.
Australian Natural Therapeutics Group (ANTG), an Aussie cannabis company has collaborated with a Canadian company to produce a staggering $400 million medical cannabis farm, set to generate 1000 new jobs.
ECS Botanics (ASX: ECS) has plans to expand its medicinal cannabis farm in Tasmania, from 2,500sqm to 320,000sqm. This would end up being one of Australia’s biggest cannabis farms and would enable revenues from worldwide.
New research from the Lambert Initiative has discovered a ‘window of impairment’ of 3 to 10 hours from using cannabis, caused by tetrahydrocannabinol (THC) in the drug. These findings could have implications on drug-driving laws.
The research, published in Neuroscience & Behavioural Reviews, has examined 80 scientific studies, performed over the past 20 years, on how THC (the psychoactive part of cannabis) effects your driving performance.
Does smoking cannabis make you psychotic? This article looks at a person’s genes, how old they are, how much THC is being ingested and what it is you are smoking. These factors could determine the risks.
Australia’s special access scheme provides medicinal cannabis to patients across the country. Over 100,000 prescriptions have been given out since the program started back in 2016, and the demand for medication just keeps growing.
The company MediPharm Labs has sent its first shipment of medical cannabis to Germany, from their facility in Wonthaggi, Victoria. The shipment contained capsules with cannabis oil inside.
A cannabis company based in the town of Wonthaggi, in Victoria, has shipped its largest ever shipment of cannabis to Germany. The medications will help to treat patients suffering from cancer related symptoms, and chronic pain.
